Literature DB >> 8039655

Genotypic and phenotypic relatedness of 80 strains of Branhamella catarrhalis of worldwide origin.

J J Christensen1, J Ursing, B Bruun.   

Abstract

80 clinical Branhamella catarrhalis strains of worldwide origin were examined for genotypic relatedness and phenotypic characteristics. Using a quantitative bacterial dot method for DNA-DNA hybridization the strains were found to form a homogeneous group with delta Tm-values ranging from 0.0-2.3 degrees C, In Minibact-N, an identification kit for oxidase positive, Gram-negative diplococci using eight phenotypic characteristics, all isolates were correctly identified and also demonstrated complete homogeneity except for beta-lactamase production. Type strains representing the genera Branhamella, Moraxella and Neisseria were also examined for comparison. B. catarrhalis strain NCTC 4103-known to be atypical-had a delta Tm-value of 5.7 degrees C and produced gamma-glutamylaminopeptidase, in contrast to all other B. catarrhalis strains. In GN MicroPlate, a kit which tests utilizable carbon sources, B. catarrhalis strains were found to be able to utilize up to 16 to 95 carbon sources.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039655     DOI: 10.1111/j.1574-6968.1994.tb06882.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  9 in total

1.  Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.

Authors:  Stefan P W de Vries; Sacha A F T van Hijum; Wolfgang Schueler; Kristian Riesbeck; John P Hays; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

2.  Short Leucine-Rich Proteoglycans Modulate Complement Activity and Increase Killing of the Respiratory Pathogen Moraxella catarrhalis.

Authors:  Maisem Laabei; Guanghui Liu; David Ermert; John D Lambris; Kristian Riesbeck; Anna M Blom
Journal:  J Immunol       Date:  2018-09-28       Impact factor: 5.422

3.  A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene.

Authors:  Stig Ove Hjelmevoll; Merethe Elise Olsen; Johanna U Ericson Sollid; Håkon Haaheim; Magnus Unemo; Vegard Skogen
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

4.  Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla.

Authors:  L O Bakaletz; D M Murwin; J M Billy
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

5.  Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates.

Authors:  Jeremiah J Davie; Josh Earl; Stefan P W de Vries; Azad Ahmed; Fen Z Hu; Hester J Bootsma; Kim Stol; Peter W M Hermans; Robert M Wadowsky; Garth D Ehrlich; John P Hays; Anthony A Campagnari
Journal:  BMC Genomics       Date:  2011-01-26       Impact factor: 3.969

Review 6.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

7.  The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.

Authors:  Andrea Möllenkvist; Therése Nordström; Christer Halldén; Jens Jørgen Christensen; Arne Forsgren; Kristian Riesbeck
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

8.  Genome sequence of Moraxella catarrhalis RH4, an isolate of seroresistant lineage.

Authors:  Aldert Zomer; Stefan P W de Vries; Kristian Riesbeck; Andreas L Meinke; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

9.  Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model.

Authors:  Margarita Smidt; Patrick Bättig; Suzanne J C Verhaegh; Axel Niebisch; Markus Hanner; Sanja Selak; Wolfgang Schüler; Eva Morfeldt; Christel Hellberg; Eszter Nagy; Urban Lundberg; John P Hays; Andreas Meinke; Birgitta Henriques-Normark
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.